Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 489221 - 489240 out of 492087 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AC07) tocilizumab (adm: P) | TYENNE 20MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TYENNE 20MG/ML INJ,SOLN | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOCILIZUMAB-AAZG 162MG/0.9ML INJ,SOLN,SYRINGE | 0.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOCILIZUMAB-AAZG 162MG/0.9ML INJ,SOLN,SYRINGE | 0.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FreseniusKabi,LLC |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA 100MG/ML INJ,PEN,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA 100MG/ML INJ,PEN,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA 100MG/ML INJ,SYR,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA 100MG/ML INJ,SYR,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AD01) ciclosporin (adm: O) | CYCLOSPORINE 100MG/ML ORAL SOLN | 50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L04AD01) ciclosporin (adm: O) | CYCLOSPORINE 100MG CAP | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L04AD01) ciclosporin (adm: O) | CYCLOSPORINE 25MG CAP | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L04AD01) ciclosporin (adm: O) | CYCLOSPORINE 50MG CAP | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L04AD01) ciclosporin (adm: O) | CYCLOSPORINE NON-MODIFIED 100MG CAP | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AvKare,LLC |
| USA | (L04AD01) ciclosporin (adm: O) | CYCLOSPORINE NON-MODIFIED 25MG CAP | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AvKare,LLC |
| USA | (L04AG) monoclonal antibodies | NIKTIMVO 22MG/0.44ML SINGLE DOSE | 0.44ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L04AG) monoclonal antibodies | NIKTIMVO 9MG/0.18ML SINGLE DOSE | 0.18ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 108MG/0.68ML INJ,SOLN,PEN | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 108MG/0.68ML INJ,SOLN,PEN | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 300MG/20ML INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 300MG/20ML INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
Pages
